Zavegepant: First Approval (vol 83, pg 825, 2023)

被引：0

作者：

Dhillon, Sohita ^{[1
]}

机构：

[1] Springer Nat, Private Bag 65901,Mairangi Bay, Auckland 0754, New Zealand

来源：

关键词：

D O I：

10.1007/s40265-023-01915-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：1

共 50 条

[31] Zastaprazan: First Approval (vol 84, pg 863, 2024)
Blair, Hannah A.
DRUGS, 2024, 84 (10) : 1333 - 1333
[32] Selpercatinib: First Approval (vol 80, pg 1119, 2020)
Markham, Anthony
DRUGS, 2021, 81 (01) : 181 - 181
[33] Sotorasib: First Approval (vol 81, pg 1573, 2021)
Blair, Hannah A.
DRUGS, 2021, 81 (16) : 1947 - 1947
[34] Ripretinib: First Approval (vol 80, pg 1133, 2020)
Dhillon, Sohita
DRUGS, 2020, 80 (18) : 1999 - 1999
[35] Abrocitinib: First Approval (vol 81, pg 2149, 2021)
Deeks, Emma D.
Duggan, Sean
DRUGS, 2022, 82 (05) : 609 - 609
[36] Infigratinib: First Approval (vol 81, pg 1355, 2021)
Kang, Connie
DRUGS, 2022, 82 (01) : 93 - 93
[37] Lenacapavir: First Approval (vol 82, pg 1499, 2022)
Paik, Julia
DRUGS, 2023, 83 (11) : 1061 - 1061
[38] Lonafarnib: First Approval (vol 81, pg 283, 2020)
Dhillon, Sohita
DRUGS, 2021, 81 (05) : 619 - 619
[39] Oliceridine: First Approval (vol 80, pg 1739, 2020)
Markham, Anthony
DRUGS, 2020, 80 (17) : 1871 - 1871
[40] First day on peds (vol 102, pg 83, 2002)
Whaite, B
AMERICAN JOURNAL OF NURSING, 2002, 102 (11) : 13 - 13